Post-Genomic Biomarker-Based Diagnostic Products are Projected To Grow From $100 Million in 2003 to $2 Billion by 2008

Research and Markets (researchandmarkets.com/reports/c8902) has announced the addition of Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics to their offering.

(PRWEB) November 10, 2004 -- Biomarkers are not new certainly their use in pharmaceutical, diagnostic, and biomedical R&D goes back several decades. So why has there been so much activity recently? For most of the latter half of the twentieth century, the appearance of a new biomarker was a relatively rare event. The rise of new genomic, proteomic, and metabonomic technologies during the past decade has provided a major acceleration in the rate of biomarker discovery and major improvement in the quality and utility of the resulting markers. The availability of these new-wave markers provides pharmaceutical companies important new opportunities for improving the time- and cost-efficiency of drug development, as well as providing diagnostic companies access to new assays that promise vast improvement in early disease detection, prognosis, and monitoring.

Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics Market Analysis Report provides deep insights into the evolution of this field, the technologies contributing to biomarker discovery and detection, emerging applications of new-wave biomarkers, and market trends. In addition, the Report presents a series of revealing interviews with key experts in this young and dynamic field, along with in-depth profiles of key companies contributing to the revolution.

This Report Will Help You

-Pinpoint the market potential of biomarkers with an examination of the projected market impact through 2008.

-Determine the competitive advantage of classical versus post-genomic biomarker technologies for discovery and detection through a comprehensive breakdown of the capabilities and limitations of both.

-Discover the commercial viability of biomarker technology platforms through a detailed breakdown of their widespread uses and applications.

-Gain reliable and thought provoking insights into the biomarkers area from dynamic interviews with authorities involved in this industry.Look inside 24 companies working within the biomarker field-including strengths and weaknesses, product pipelines, alliances, business strategies, and more.

Table of Contents

1 Executive Summary

2 Introduction

3 Technology Background

4 Market Considerations Underlying the Biomarker Revolution

5 Technologies for Discovering and Detecting Biomarkers

6 Biomarker Applications

7 Commercial Implications of Biomarkers

8 The Future of Biomarkers

9 Company Profiles

10 Interviews with Industry Experts

11 Bibliography

For more information visit http://www.researchandmarkets.com/reports/c8902

Laura Wood

Senior Manager

Research and Markets

press@researchandmarkets.com

Fax: +353 1 4100 980

###